Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycine supplementation for isovaleric acidemia
jRCT1071220102Recruiting
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of glycine in isovaleric acidemia (IVA). Primary endpoint: Number of acute metabolic crisis. Started Apr 2020; status: recruiting.
02
Drugs
glycine
03
Conditions
isovaleric acidemia (IVA)
Beyond the preview
Go deeper on jRCT1071220102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071220102.